The new law raises the age threshold for the onset of disabling conditions that make people eligible to have the savings accounts. The money in the accounts do not count toward the limits for Medicaid and the Supplemental Nutritional Assistance Program.
In December 2022, the omnibus spending bill passed by Congress and signed by President Joe Biden bill included the ABLE Age Adjustment Act. The new law raises the age threshold of eligibility to open an ABLE savings account from 26 years to 46 years of age at the onset of a qualifying disability. Before the age adjustment, only individuals with an onset of disability before the age of 26 qualified to open an ABLE account. Given that the age of onset for multiple sclerosis (MS) typically falls between 20 and 40 years, many people living with MS have been left out of participating in ABLE savings accounts.
ABLE is short Achieving a Better Life Experience Act, which was enacted in 2014. The ABLE act created savings accounts that allow Americans with disabilities to save money without affecting their need-based programs, such as Medicaid, Supplemental Security Income and the Supplemental Nutrition Assistance Program (formerly known as food stampp). With these programs, people are typically limited to $2,000 in savings and other liquid assets in order to qualify. However, any money saved in an ABLE account does not count toward that number.
ABLE accounts, also known as 529A accounts, are modeled after 529 college savings plans. Currently, they are available in 46 states and Washington, D.C., and offer tax-free distributions if used for qualifying expenses. These include healthcare expenses, housing, food, transportation and other personal services.
Anyone can contribute to a beneficiary’s account, but there are annual contribution limits. In 2023, the maximum contribution is $17,000. However, if an individual with an ABLE account works, they can contribute an additional $13,590 per year from their earnings.
The new eligibility age threshold will not go into effect until January 2026, but according to The New York Times, an additional 6 million people will qualify for ABLE accounts when the rule goes into effect. This would include people diagnosed with MS and other neurological conditions well after their mid-twenties.
Diabetes Weight Loss Drugs Could be Linked to Reduced Risk of MS, Study Finds
April 12th 2024Drug repurposing has recently emerged as an attractive pathway for developing new treatments due to its relatively fast and cost-efficient trajectory. Because obesity and MS share inflammatory properties, researchers used data from the FDA Adverse Event Reporting System to investigate the association between weight loss-inducing drugs and MS
Read More
Specialty Pharmacist Interventions Result in More Than $150,000 in Cost Avoidance For MS Patients
April 4th 2024Darina Georgieva, Pharm.D., and her colleagues from the department of pharmaceutical services at Vanderbilt University Medical Center, conducted a retrospective observational study to learn the costs avoided through specialty pharmacist interventions for patients at the Vanderbilt MS Clinic. The study results were published in the Journal of Managed Care and Specialty Pharmacy earlier this month.
Read More
Ozanimod Shows Sustained Efficacy in Long-term Study for Multiple Sclerosis Treatment
March 11th 2024Long-term data from the phase 3 DAYBREAK trial affirmed sustained efficacy of ozanimod for relapsing forms of multiple sclerosis, with a high amount of patients who were relapse-free at 6 years.
Read More